Sign in

CIK 0000921114

  • Non-accelerated filer
  • Smaller reporting company

Armata Pharmaceuticals, Inc.

Sign in to watch
Ticker
ARMP
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911549568
Phone
+1 310-665-2928
Business address
5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
Former names
AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 22 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-25 Martin Steven Robert Chief Financial Officer Grant or award · Stock Option (Right to Buy) +56,000 56,000
2020-12-08 Martin Steven Robert Chief Financial Officer Grant or award · Stock Option (Right to Buy) +23,000 23,000
2019-05-22 Martin Steven Robert Chief Financial Officer Grant or award · Stock Option (Right to Buy) +149,362 149,362
2017-09-07 Martin Steven Robert Chief Financial Officer Grant or award · Stock Option (Right to Buy) +139,000 139,000
2017-04-01 Martin Steven Robert Chief Financial Officer Grant or award · Stock Option (Right to Buy) +161,290 161,290
2016-12-09 Martin Steven Robert Chief Financial Officer Grant or award +3,760 $0.39 $1K 3,760
2016-01-18 Martin Steven Robert Chief Financial Officer Grant or award · Stock Option (Right to Buy) +99,919 99,919

Page 1 of 1 · 7 trades